Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander artikel

Gepubliceerd in: Quality of Life Research 5/2007

01-06-2007 | Original Paper

Relation between level or change of hemoglobin and generic and disease-specific quality of life measures in hemodialysis

Auteurs: Laura C. Plantinga, Nancy E. Fink, Bernard G. Jaar, I-Chan Huang, Albert W. Wu, Klemens B. Meyer, Neil R. Powe

Gepubliceerd in: Quality of Life Research | Uitgave 5/2007

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Objective

We sought to examine the relation between meeting or exceeding the current minimum guideline for hemoglobin (11 g/dl) in dialysis patients and generic and disease-specific QOL scores at 1 year.

Methods

In 438 incident hemodialysis patients from a national prospective cohort study, we used regression models to predict QOL score (all scaled 0–100) at 1 year using 6-month values of hemoglobin, adjusting for potential confounders.

Results

Compared to values <11 g/dl, hemoglobin ≥11 g/dl at 6 months was associated with higher scores for the general domains of physical functioning, role physical, mental health, social functioning, and bodily pain at 1 year; cognitive function, diet restriction, and dialysis access dialysis-specific domain scores were also higher for these patients. Each 1 g/dl greater hemoglobin was also statistically significantly associated with higher QOL scores for most domains. In longitudinal analyses, most of the domains showed that, with each 1 g/dl increase in hemoglobin concentration from baseline to 6 months, QOL score increased significantly over the first year.

Conclusions

Hemodialysis patients who attain higher hemoglobin concentration at 6 months, especially ≥11 g/dl, have better QOL at 1 year, with regard to important physical, mental, social, and cognitive domains.
Literatuur
1.
go back to reference Astor, B. C., Eustace, J. A., Powe, N. R., Klag, M. J., Sadler, J. H., Fink, N. E., & Coresh, J. (2001). Timing of nephrologist referral and arteriovenous access use: the CHOICE Study. American Journal of Kidney Diseases, 38, 494–501. PubMed Astor, B. C., Eustace, J. A., Powe, N. R., Klag, M. J., Sadler, J. H., Fink, N. E., & Coresh, J. (2001). Timing of nephrologist referral and arteriovenous access use: the CHOICE Study. American Journal of Kidney Diseases, 38, 494–501. PubMed
2.
go back to reference Athienites, N. V., Miskulin, D. C., Fernandez, G., Bunnapradist, S., Simon, G., Landa, M., Schmid, C. H., Greenfield, S., Levey, A. S., & Meyer, K. B. (2000). Comorbidity assessment in hemodialysis and peritoneal dialysis using the index of coexistent disease. Seminars in Dialysis, 13, 320–326. PubMedCrossRef Athienites, N. V., Miskulin, D. C., Fernandez, G., Bunnapradist, S., Simon, G., Landa, M., Schmid, C. H., Greenfield, S., Levey, A. S., & Meyer, K. B. (2000). Comorbidity assessment in hemodialysis and peritoneal dialysis using the index of coexistent disease. Seminars in Dialysis, 13, 320–326. PubMedCrossRef
3.
go back to reference Baiardi, F., Degli, E. E., Cocchi, R., Fabbri, A., Sturani, A., Valpiani, G., & Fusarol, M. (2002). Effects of clinical and individual variables on quality of life in chronic renal failure patients. Journal of Nephrology, 15, 61–67. PubMed Baiardi, F., Degli, E. E., Cocchi, R., Fabbri, A., Sturani, A., Valpiani, G., & Fusarol, M. (2002). Effects of clinical and individual variables on quality of life in chronic renal failure patients. Journal of Nephrology, 15, 61–67. PubMed
4.
go back to reference Berns, J. S. (2005). Should the target hemoglobin for patients with chronic kidney disease treated with erythropoietic replacement therapy be changed? Seminars in Dialysis, 18, 22–29. PubMedCrossRef Berns, J. S. (2005). Should the target hemoglobin for patients with chronic kidney disease treated with erythropoietic replacement therapy be changed? Seminars in Dialysis, 18, 22–29. PubMedCrossRef
5.
go back to reference Besarab, A., Bolton, W. K., Browne, J. K., Egrie, J. C., Nissenson, A. R., Okamoto, D. M., Schwab, S. J., & Goodkin, D. A. (1998). The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. New England Journal of Medicine, 339, 584–590. PubMedCrossRef Besarab, A., Bolton, W. K., Browne, J. K., Egrie, J. C., Nissenson, A. R., Okamoto, D. M., Schwab, S. J., & Goodkin, D. A. (1998). The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. New England Journal of Medicine, 339, 584–590. PubMedCrossRef
6.
go back to reference Breiterman-White, R. (2005). Functional ability of patients on dialysis: the critical role of anemia. Nephrology Nursing Journal 32, 79–82. PubMed Breiterman-White, R. (2005). Functional ability of patients on dialysis: the critical role of anemia. Nephrology Nursing Journal 32, 79–82. PubMed
7.
go back to reference Centers for Medicare & Medicaid Services (2005) Centers for Medicare & Medicaid Services Claims Monitoring Policy: Erythropoietin/darbepoietin alfa Usage for Beneficiaries with End Stage Renal Disease. Centers for Medicare & Medicaid Services (2005) Centers for Medicare & Medicaid Services Claims Monitoring Policy: Erythropoietin/darbepoietin alfa Usage for Beneficiaries with End Stage Renal Disease.
8.
go back to reference Collins, A. J., Ma, J. Z., Xia, A., & Ebben, J. (1998). Trends in anemia treatment with erythropoietin usage and patient outcomes. American Journal of Kidney Diseases, 32, S133–S141. PubMed Collins, A. J., Ma, J. Z., Xia, A., & Ebben, J. (1998). Trends in anemia treatment with erythropoietin usage and patient outcomes. American Journal of Kidney Diseases, 32, S133–S141. PubMed
9.
go back to reference Daugirdas, J. T. (1993). Second-generation logarithmic estimates of single-pool variable volume of Kt/V: an analysis of error. Journal of the American Society of Nephrology, 4, 1204–1213. Daugirdas, J. T. (1993). Second-generation logarithmic estimates of single-pool variable volume of Kt/V: an analysis of error. Journal of the American Society of Nephrology, 4, 1204–1213.
10.
go back to reference Eschbach, J. W. (1993). Erythropoietin is not a cause of access thrombosis. Seminars in Dialysis, 6, 180–184. Eschbach, J. W. (1993). Erythropoietin is not a cause of access thrombosis. Seminars in Dialysis, 6, 180–184.
11.
go back to reference Evans, R. W., Rader, B., & Manninen D. L. (1990). The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. Cooperative Multicenter EPO Clinical Trial Group. The Journal of the American Medical Association, 263, 825–830. CrossRef Evans, R. W., Rader, B., & Manninen D. L. (1990). The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. Cooperative Multicenter EPO Clinical Trial Group. The Journal of the American Medical Association, 263, 825–830. CrossRef
12.
go back to reference Foley, R. N., Parfrey, P. S., Harnett, J. D., Kent, G. M., Murray, D. C., & Barre, P. E. (1996). The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. American Journal of Kidney Diseases, 28, 53–61. PubMed Foley, R. N., Parfrey, P. S., Harnett, J. D., Kent, G. M., Murray, D. C., & Barre, P. E. (1996). The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. American Journal of Kidney Diseases, 28, 53–61. PubMed
13.
go back to reference Furuland, H., Linde, T., Ahlmen, J., Christensson, A., Strombom, U., & Danielson, B. G. (2003). A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients. Nephrology, Dialysis, Transplantion, 18, 353–361. CrossRef Furuland, H., Linde, T., Ahlmen, J., Christensson, A., Strombom, U., & Danielson, B. G. (2003). A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients. Nephrology, Dialysis, Transplantion, 18, 353–361. CrossRef
14.
go back to reference Greenfield, S., Apolone, G., McNeil, B. J., & Cleary, P. D. (1993). The importance of coexistent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement. Medical Care, 31, 141–154. PubMedCrossRef Greenfield, S., Apolone, G., McNeil, B. J., & Cleary, P. D. (1993). The importance of coexistent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement. Medical Care, 31, 141–154. PubMedCrossRef
15.
go back to reference Gregory, N. (2005). Quality of life in patients on dialysis: benefits of maintaining a hemoglobin of 11 to 12 g/dL. Nephrology Nursing Journal, 32, 307–310. PubMed Gregory, N. (2005). Quality of life in patients on dialysis: benefits of maintaining a hemoglobin of 11 to 12 g/dL. Nephrology Nursing Journal, 32, 307–310. PubMed
16.
go back to reference Hays, R. D., Farivar, S. S., & Liu, H. (2005). Approaches and recommendations for estimating minimally important differences for health-related quality of life measures. COPD:. J ournal of Chronic Obstructive Pulmonary Disease, 2, 63–67. Hays, R. D., Farivar, S. S., & Liu, H. (2005). Approaches and recommendations for estimating minimally important differences for health-related quality of life measures. COPD:. J ournal of Chronic Obstructive Pulmonary Disease, 2, 63–67.
17.
go back to reference Hudis, C. A., Vogel, C. L., Gralow, J. R., & Williams, D. (2005). Weekly epoetin alfa during adjuvant chemotherapy for breast cancer: effect on hemoglobin levels and quality of life. Clinical Breast Cancer, 6, 132–142. PubMedCrossRef Hudis, C. A., Vogel, C. L., Gralow, J. R., & Williams, D. (2005). Weekly epoetin alfa during adjuvant chemotherapy for breast cancer: effect on hemoglobin levels and quality of life. Clinical Breast Cancer, 6, 132–142. PubMedCrossRef
18.
go back to reference Kalantar-Zadeh, K., Kopple, J. D., Block, G., & Humphreys, M. H. (2001). Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis. Journal of the American Society of Nephrology, 12, 2797–2806. PubMed Kalantar-Zadeh, K., Kopple, J. D., Block, G., & Humphreys, M. H. (2001). Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis. Journal of the American Society of Nephrology, 12, 2797–2806. PubMed
19.
go back to reference Lawrence, I. G., Price, D. E., Howlett, T. A., Harris, K. P., Feehally, J., & Walls, J. (1997). Erythropoietin and sexual dysfunction. Nephrology, Dialysis, Transplantion, 12, 741–747. CrossRef Lawrence, I. G., Price, D. E., Howlett, T. A., Harris, K. P., Feehally, J., & Walls, J. (1997). Erythropoietin and sexual dysfunction. Nephrology, Dialysis, Transplantion, 12, 741–747. CrossRef
20.
go back to reference Lim, V. S. (1987). Reproductive function in patients with renal insufficiency. American Journal of Kidney Diseases, 9:363–367. PubMed Lim, V. S. (1987). Reproductive function in patients with renal insufficiency. American Journal of Kidney Diseases, 9:363–367. PubMed
21.
go back to reference Lin, D. Y., & Wei, L. J. (1989). The robust inference for the Cox proportional hazards model. Journal of the American Statistical Association, 84, 1074–1078. CrossRef Lin, D. Y., & Wei, L. J. (1989). The robust inference for the Cox proportional hazards model. Journal of the American Statistical Association, 84, 1074–1078. CrossRef
22.
go back to reference Localio, A. R., Berlin, J. A., Ten, Have, T. R., & Kimmel, S. E. (2001). Adjustments for center in multicenter studies: an overview. Annals of International Medicine, 135, 112–123. Localio, A. R., Berlin, J. A., Ten, Have, T. R., & Kimmel, S. E. (2001). Adjustments for center in multicenter studies: an overview. Annals of International Medicine, 135, 112–123.
23.
go back to reference Ma, J. Z., Ebben, J., Xia, H., & Collins, A. J. (1999). Hematocrit level and associated mortality in hemodialysis patients. Journal of the American Society of Nephrology, 10, 610–619. PubMed Ma, J. Z., Ebben, J., Xia, H., & Collins, A. J. (1999). Hematocrit level and associated mortality in hemodialysis patients. Journal of the American Society of Nephrology, 10, 610–619. PubMed
24.
go back to reference Mapes, D. L., Lopes, A. A., Satayathum, S, McCullough, K. P., Goodkin, D. A., Locatelli, F., Fukuhara, S., Young, E. W., Kurokawa, K., Saito, A., Bommer, J., Wolfe, R. A., Held, P. J., & Port, F. K. (2003). Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney International, 64, 339–349. PubMedCrossRef Mapes, D. L., Lopes, A. A., Satayathum, S, McCullough, K. P., Goodkin, D. A., Locatelli, F., Fukuhara, S., Young, E. W., Kurokawa, K., Saito, A., Bommer, J., Wolfe, R. A., Held, P. J., & Port, F. K. (2003). Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney International, 64, 339–349. PubMedCrossRef
25.
go back to reference Miskulin, D. C., Meyer, K. B., Athienites, N. V., Martin, A. A., Terrin, N., Marsh, J. V., Fink, N. E., Coresh, J., Powe, N. R., Klag, M. J., & Levey, A. S. (2000). Comorbidity and other factors associated with modality selection in incident dialysis patients: the CHOICE Study. Choices for Healthy Outcomes in Caring for End-Stage Renal Disease. American Journal of Kidney Diseases, 39, 324–336. Miskulin, D. C., Meyer, K. B., Athienites, N. V., Martin, A. A., Terrin, N., Marsh, J. V., Fink, N. E., Coresh, J., Powe, N. R., Klag, M. J., & Levey, A. S. (2000). Comorbidity and other factors associated with modality selection in incident dialysis patients: the CHOICE Study. Choices for Healthy Outcomes in Caring for End-Stage Renal Disease. American Journal of Kidney Diseases, 39, 324–336.
26.
go back to reference Miskulin, D. C., Athienites, N. V., Yan, G., Martin, A. A., Ornt, D. B., Kusek, J. W., Meyer, K. B., & Levey, A. S. (2001). Comorbidity assessment using the Index of Coexistent Diseases in a multi-center clinical trial. Kidney International, 60, 1498–1510. PubMedCrossRef Miskulin, D. C., Athienites, N. V., Yan, G., Martin, A. A., Ornt, D. B., Kusek, J. W., Meyer, K. B., & Levey, A. S. (2001). Comorbidity assessment using the Index of Coexistent Diseases in a multi-center clinical trial. Kidney International, 60, 1498–1510. PubMedCrossRef
27.
go back to reference Moreno, F., Sanz-Guajardo, D., Lopez-Gomez, J. M., Jofre, R., & Valderrabano, F. (2000). Increasing the hematocrit has a beneficial effect on quality of life and is safe in selected hemodialysis patients. Spanish Cooperative Renal Patients Quality of Life Study Group of the Spanish Society of Nephrology. Journal of the American Society of Nephrology, 11, 335–342. PubMed Moreno, F., Sanz-Guajardo, D., Lopez-Gomez, J. M., Jofre, R., & Valderrabano, F. (2000). Increasing the hematocrit has a beneficial effect on quality of life and is safe in selected hemodialysis patients. Spanish Cooperative Renal Patients Quality of Life Study Group of the Spanish Society of Nephrology. Journal of the American Society of Nephrology, 11, 335–342. PubMed
28.
go back to reference Muirhead, N. (1993). Erythropoietin is a cause of access thrombosis. Seminars in Dialysis, 6, 184–188. Muirhead, N. (1993). Erythropoietin is a cause of access thrombosis. Seminars in Dialysis, 6, 184–188.
29.
go back to reference National Kidney Foundation (2005). Kidney Disease Outcomes Quality Initiative (KDOQI). Clinical Practice Guidelines. Available at: http://​www.​kidney.​org/​professionals/​kdoqi/​guidelines.​cfm.​ 2005. New York, NY, National Kidney Foundation. National Kidney Foundation (2005). Kidney Disease Outcomes Quality Initiative (KDOQI). Clinical Practice Guidelines. Available at: http://​www.​kidney.​org/​professionals/​kdoqi/​guidelines.​cfm.​ 2005. New York, NY, National Kidney Foundation.
30.
go back to reference Parfrey, P. S., Foley, R. N., Wittreich, B. H., Sullivan, D. J., Zagari, M. J., & Frei, D. (2005). Double- blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease. Journal of the American Society of Nephrology, 16(7), 2180–2189. PubMedCrossRef Parfrey, P. S., Foley, R. N., Wittreich, B. H., Sullivan, D. J., Zagari, M. J., & Frei, D. (2005). Double- blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease. Journal of the American Society of Nephrology, 16(7), 2180–2189. PubMedCrossRef
31.
go back to reference Perlman, R. L., Finkelstein, F. O., Liu, L., Roys, E., Kiser, M., Eisele, G., Burrows-Hudson, S., Messana, J. M., Levin, N., Rajagopalan, S., Port, F. K., Wolfe, R. A., & Saran, R. (2005). Quality of life in chronic kidney disease (CKD): a cross-sectional analysis in the Renal Research Institute-CKD study. American Journal of Kidney Diseases, 45, 658–666. PubMedCrossRef Perlman, R. L., Finkelstein, F. O., Liu, L., Roys, E., Kiser, M., Eisele, G., Burrows-Hudson, S., Messana, J. M., Levin, N., Rajagopalan, S., Port, F. K., Wolfe, R. A., & Saran, R. (2005). Quality of life in chronic kidney disease (CKD): a cross-sectional analysis in the Renal Research Institute-CKD study. American Journal of Kidney Diseases, 45, 658–666. PubMedCrossRef
32.
go back to reference Powe, N. R., Klag, M. J., Sadler, J. H., Anderson, G. F., Bass, E. B., Briggs, W. A., Fink, N. E., Levey, A. S., Levin, N. W., Meyer, K. B., Rubin, H. R., & Wu, A. W. (1996). Choices for healthy outcomes in caring for end stage renal disease. Seminars in Dialysis, 9, 9–11. Powe, N. R., Klag, M. J., Sadler, J. H., Anderson, G. F., Bass, E. B., Briggs, W. A., Fink, N. E., Levey, A. S., Levin, N. W., Meyer, K. B., Rubin, H. R., & Wu, A. W. (1996). Choices for healthy outcomes in caring for end stage renal disease. Seminars in Dialysis, 9, 9–11.
33.
go back to reference Schatell, D., & Witten, B. (2004). Anemia: dialysis patients experiences. Nephrology News & Issues, 18, 49–54. Schatell, D., & Witten, B. (2004). Anemia: dialysis patients experiences. Nephrology News & Issues, 18, 49–54.
34.
go back to reference Semba, R. D., Martin, B. K., Kempen, J. H., Thorne, J. E., & Wu, A. W. (2005). The impact of anemia on energy and physical functioning in individuals with AIDS. Archives of Internal Medicine 165, 2229–2236. PubMedCrossRef Semba, R. D., Martin, B. K., Kempen, J. H., Thorne, J. E., & Wu, A. W. (2005). The impact of anemia on energy and physical functioning in individuals with AIDS. Archives of Internal Medicine 165, 2229–2236. PubMedCrossRef
35.
go back to reference Stivelman, J. C. (2000). Benefits of anaemia treatment on cognitive function. Nephrology, Dialysis, Transplantation, 15(Suppl 3), 29–35. PubMed Stivelman, J. C. (2000). Benefits of anaemia treatment on cognitive function. Nephrology, Dialysis, Transplantation, 15(Suppl 3), 29–35. PubMed
36.
go back to reference Taft, C., Karlsson, J., & Sullivan, M. (2001). Do SF-36 summary component scores accurately summarize subscale scores? Quality of Life Research, 10, 395–404. PubMedCrossRef Taft, C., Karlsson, J., & Sullivan, M. (2001). Do SF-36 summary component scores accurately summarize subscale scores? Quality of Life Research, 10, 395–404. PubMedCrossRef
37.
go back to reference Taji, Y., Morimoto, T., Okada, K., Fukuhara, S., Fukui, T., & Kuwahara, T. (2004). Effects of intravenous ascorbic acid on erythropoiesis and quality of life in unselected hemodialysis patients. Journal of Nephrology, 17, 537–543. PubMed Taji, Y., Morimoto, T., Okada, K., Fukuhara, S., Fukui, T., & Kuwahara, T. (2004). Effects of intravenous ascorbic acid on erythropoiesis and quality of life in unselected hemodialysis patients. Journal of Nephrology, 17, 537–543. PubMed
38.
go back to reference Tonelli, M., Winkelmayer, W. C., Jindal, K. K., Owen, W. F., & Manns, B. J. (2003). The cost-effectiveness of maintaining higher hemoglobin targets with erythropoietin in hemodialysis patients. Kidney International, 64, 295–304. PubMedCrossRef Tonelli, M., Winkelmayer, W. C., Jindal, K. K., Owen, W. F., & Manns, B. J. (2003). The cost-effectiveness of maintaining higher hemoglobin targets with erythropoietin in hemodialysis patients. Kidney International, 64, 295–304. PubMedCrossRef
39.
go back to reference Valderrabano, F. (2000). Quality of life benefits of early anaemia treatment. Nephrology, Dialysis, Transplantation, 15(Suppl 3), 23–28. PubMed Valderrabano, F. (2000). Quality of life benefits of early anaemia treatment. Nephrology, Dialysis, Transplantation, 15(Suppl 3), 23–28. PubMed
40.
go back to reference Valderrabano, F., Jofre, R., & Lopez-Gomez, J. M. (2001). Quality of life in end-stage renal disease patients. American Journal of Kidney Disease, 38, 443–464. Valderrabano, F., Jofre, R., & Lopez-Gomez, J. M. (2001). Quality of life in end-stage renal disease patients. American Journal of Kidney Disease, 38, 443–464.
41.
go back to reference Vazquez, I., Valderrabano, F., Jofre, R., Fort, J., Lopez-Gomez, J. M., Moreno, F, & Sanz-Guajardo, D. (2003). Psychosocial factors and quality of life in young hemodialysis patients with low comorbidity. Journal of Nephrology, 16, 886–894. PubMed Vazquez, I., Valderrabano, F., Jofre, R., Fort, J., Lopez-Gomez, J. M., Moreno, F, & Sanz-Guajardo, D. (2003). Psychosocial factors and quality of life in young hemodialysis patients with low comorbidity. Journal of Nephrology, 16, 886–894. PubMed
42.
go back to reference Ware, J. E. Jr (1993). SF-36 Health Survey: Manual & Interpretation Guide. Boston, MA: The New England Medical Center Health Institute. Ware, J. E. Jr (1993). SF-36 Health Survey: Manual & Interpretation Guide. Boston, MA: The New England Medical Center Health Institute.
43.
go back to reference Wei, L. J., Lin, D. Y., & Weissfeld, L. (1989). Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. Journal of the American Statistical Association, 84, 1065–1073. CrossRef Wei, L. J., Lin, D. Y., & Weissfeld, L. (1989). Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. Journal of the American Statistical Association, 84, 1065–1073. CrossRef
44.
go back to reference Wu, A. W., Fink, N. E., Cagney, K. A., Bass, E. B., Rubin, H. R., Meyer, K. B., Sadler, J. H., & Powe, N. R. (2001). Developing a health-related quality-of-life measure for end-stage renal disease: The CHOICE Health Experience Questionnaire. American Journal of Kidney Diseases, 37, 11–21. PubMed Wu, A. W., Fink, N. E., Cagney, K. A., Bass, E. B., Rubin, H. R., Meyer, K. B., Sadler, J. H., & Powe, N. R. (2001). Developing a health-related quality-of-life measure for end-stage renal disease: The CHOICE Health Experience Questionnaire. American Journal of Kidney Diseases, 37, 11–21. PubMed
45.
go back to reference Xia, H., Ebben, J., Ma, J. Z., & Collins, A. J. (1999). Hematocrit levels and hospitalization risks in hemodialysis patients. Journal of the American Society of Nephrology, 10, 1309–1316. PubMed Xia, H., Ebben, J., Ma, J. Z., & Collins, A. J. (1999). Hematocrit levels and hospitalization risks in hemodialysis patients. Journal of the American Society of Nephrology, 10, 1309–1316. PubMed
46.
go back to reference Yang, S. C., Kuo, P. W., Wang, J. D., Lin, M. I., & Su, S. (2005). Quality of life and its determinants of hemodialysis patients in Taiwan measured with WHOQOL-BREF(TW). American Journal of Kidney Disorders, 46, 635–641. CrossRef Yang, S. C., Kuo, P. W., Wang, J. D., Lin, M. I., & Su, S. (2005). Quality of life and its determinants of hemodialysis patients in Taiwan measured with WHOQOL-BREF(TW). American Journal of Kidney Disorders, 46, 635–641. CrossRef
Metagegevens
Titel
Relation between level or change of hemoglobin and generic and disease-specific quality of life measures in hemodialysis
Auteurs
Laura C. Plantinga
Nancy E. Fink
Bernard G. Jaar
I-Chan Huang
Albert W. Wu
Klemens B. Meyer
Neil R. Powe
Publicatiedatum
01-06-2007
Uitgeverij
Kluwer Academic Publishers
Gepubliceerd in
Quality of Life Research / Uitgave 5/2007
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-007-9176-6